JP2014503593A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503593A5
JP2014503593A5 JP2013551354A JP2013551354A JP2014503593A5 JP 2014503593 A5 JP2014503593 A5 JP 2014503593A5 JP 2013551354 A JP2013551354 A JP 2013551354A JP 2013551354 A JP2013551354 A JP 2013551354A JP 2014503593 A5 JP2014503593 A5 JP 2014503593A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
subject
serum concentration
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013551354A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503593A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/022825 external-priority patent/WO2012103398A2/en
Publication of JP2014503593A publication Critical patent/JP2014503593A/ja
Publication of JP2014503593A5 publication Critical patent/JP2014503593A5/ja
Pending legal-status Critical Current

Links

JP2013551354A 2011-01-28 2012-01-27 閉塞性睡眠時無呼吸を処置するための方法 Pending JP2014503593A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161437272P 2011-01-28 2011-01-28
US61/437,272 2011-01-28
PCT/US2012/022825 WO2012103398A2 (en) 2011-01-28 2012-01-27 Methods for treating obstructive sleep apnea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017000145A Division JP6342525B2 (ja) 2011-01-28 2017-01-04 閉塞性睡眠時無呼吸を処置するための方法

Publications (2)

Publication Number Publication Date
JP2014503593A JP2014503593A (ja) 2014-02-13
JP2014503593A5 true JP2014503593A5 (https=) 2015-03-19

Family

ID=46577943

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013551354A Pending JP2014503593A (ja) 2011-01-28 2012-01-27 閉塞性睡眠時無呼吸を処置するための方法
JP2017000145A Active JP6342525B2 (ja) 2011-01-28 2017-01-04 閉塞性睡眠時無呼吸を処置するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017000145A Active JP6342525B2 (ja) 2011-01-28 2017-01-04 閉塞性睡眠時無呼吸を処置するための方法

Country Status (6)

Country Link
US (2) US8753327B2 (https=)
EP (1) EP2672972B1 (https=)
JP (2) JP2014503593A (https=)
CN (2) CN103458899A (https=)
CA (1) CA2825309C (https=)
WO (1) WO2012103398A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2825309C (en) * 2011-01-28 2019-10-01 Pfantastic Medical Research Institute, Llc Pyridostigmine for the treatment of obstructive sleep apnea
EP3446663A1 (en) * 2014-03-03 2019-02-27 Sleep Innovations Pty Ltd Device and method for sleep apnoea treatment
US10166268B2 (en) 2014-07-25 2019-01-01 The George Washington University Oxytocin improves treatment of obstructive sleep apnea
CN111603643B (zh) 2015-04-02 2023-05-23 希尔-罗姆服务私人有限公司 呼吸装置的压力控制
WO2018115351A1 (en) * 2016-12-23 2018-06-28 Koninklijke Philips N.V. System for treating snoring among at least two users
AU2018260666B2 (en) * 2017-04-28 2022-07-21 The Brigham And Women's Hospital, Inc. Methods and compositions for treating sleep apnea
EP3746126B1 (en) 2018-01-30 2024-07-31 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea or simple snoring
ES2861153T3 (es) * 2018-06-18 2021-10-05 Composiciones de liberación prolongada que comprenden piridostigmina
EP3840806B1 (en) * 2018-08-24 2023-10-11 Koninklijke Philips N.V. Providing sleep therapy with a pressure therapy system
EP4635514A3 (en) 2019-02-08 2025-12-24 The Brigham & Women's Hospital, Inc. Methods and compositions for treating sleep apnea
US11654283B2 (en) 2019-03-06 2023-05-23 Medtronic Xomed, Inc. Obstructive sleep apnea patient programmer for implantable devices
CN114504643B (zh) * 2021-12-24 2024-03-26 北京大学第一医院 抗IgE抗体在用于治疗OSAS中的应用
KR20250124853A (ko) * 2022-12-28 2025-08-20 니시카와 가부시키가이샤 건강 리스크 판정 시스템, 자율 신경 판정 시스템, 생활 개선 시스템, 수면 자세 판정 시스템, 수면 자세 판정 프로그램, 이갈이 검출 시스템, 및 이갈이 검출 프로그램
CN117402958A (zh) * 2023-10-26 2024-01-16 天津医科大学总医院 Claudin3及家族相关分子对阻塞性睡眠呼吸暂停低通气综合征的诊断价值

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2247662B (en) 1990-08-31 1994-11-02 Instance Ltd David J Labels and manufacture thereof
SE9504537D0 (sv) * 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
WO2005016327A2 (en) * 2003-08-13 2005-02-24 Janssen Pharmaceutica, N.V. Treatment of sleep disorders with cholinesterase inhibitors
EP1928445A1 (en) * 2005-09-16 2008-06-11 Cereuscience AB Method and means of preventing and treating sleep disordered breathing
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US7984714B2 (en) * 2006-09-29 2011-07-26 Nellcor Puritan Bennett Llc Managing obstructive sleep apnea and/or snoring using local time released agents
CA2825309C (en) * 2011-01-28 2019-10-01 Pfantastic Medical Research Institute, Llc Pyridostigmine for the treatment of obstructive sleep apnea

Similar Documents

Publication Publication Date Title
JP2014503593A5 (https=)
JP2013509429A5 (https=)
JP2012512907A5 (https=)
JP2013525444A5 (https=)
JP2013518107A5 (https=)
CY1111500T1 (el) Οπιοειδη για τη θεραπεια χρονιας αποφρακτικης πνευμονοπαθειας (copd)
JP2015515475A5 (https=)
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
JP2014528474A5 (https=)
JP2014505107A5 (https=)
JP2006143751A5 (https=)
BR112013030977A2 (pt) composição destinada ao tratamento de diabetes, compreendendo conjugado de insulina de ação prolongada e conjugado de peptídeo insulinotrópico de ação prolongada
JP2014515351A5 (https=)
JP2010518061A5 (https=)
JP2012503668A5 (https=)
JP2011527332A5 (https=)
IL292465B1 (en) Neuroactive compounds and methods of using them
EA201401354A1 (ru) Новая дозированная форма и препарат, содержащий абедитерол
JP2011527333A5 (https=)
JP2014507477A5 (https=)
JP2017501140A5 (https=)
JP2014532722A5 (https=)
CN103717571B8 (zh) 9‑氨基甲基取代的四环素类化合物
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
JP2017500289A5 (https=)